Kalyra Pharmaceuticals, Inc. — Form D
Kalyra Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-21. The offering totals $6.0M, of which $5.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-08-21
- Form: D
- Accession: 0001584696-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $5.2M
- Remaining: $827K
- Investors: 19
- Date of first sale: 2013-08-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-201695
Issuer
- Name: Kalyra Pharmaceuticals, Inc.
- CIK: 0001584696
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2012
- Address: 6181 CORNERSTONE COURT, SAN DIEGO, CA, 92121
- Phone: (858) 901-1942
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ned A Israelsen | Executive Officer | San Diego, CA |
| Scott L Glenn | Director | Boulder, CO |
| Cam L Garner | Director | San Diego, CA |
| Cam L Gallagher | Executive Officer | San Diego, CA |
| Ned A Israelsen | Director | San Diego, CA |
| Dirk A Thye | Director | San Diego, CA |
| Kevin D Bunker | Director | San Diego, CA |
| Kevin D Bunker | Executive Officer | San Diego, CA |
| Michael E Breede | Director | San Deigo, CA |
Other filings by this issuer (1)
More